Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 2
1976 1
1977 2
1978 4
1979 4
1980 9
1981 17
1982 22
1983 28
1984 16
1985 19
1986 34
1987 26
1988 37
1989 29
1990 25
1991 35
1992 41
1993 43
1994 63
1995 55
1996 67
1997 63
1998 84
1999 90
2000 102
2001 108
2002 104
2003 139
2004 118
2005 109
2006 117
2007 143
2008 156
2009 171
2010 161
2011 203
2012 238
2013 234
2014 232
2015 202
2016 151
2017 96
2018 140
2019 142
2020 163
2021 188
2022 163
2023 154
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

4,095 results

Results by year

Filters applied: . Clear all
Page 1
The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S, Izumi K, Mizokami A. Kadomoto S, et al. Among authors: izumi k. Int J Mol Sci. 2020 Jul 22;21(15):5186. doi: 10.3390/ijms21155186. Int J Mol Sci. 2020. PMID: 32707869 Free PMC article. Review.
Fucosylation of HLA-DRB1 regulates CD4(+) T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy.
Lester DK, Burton C, Gardner A, Innamarato P, Kodumudi K, Liu Q, Adhikari E, Ming Q, Williamson DB, Frederick DT, Sharova T, White MG, Markowitz J, Cao B, Nguyen J, Johnson J, Beatty M, Mockabee-Macias A, Mercurio M, Watson G, Chen PL, McCarthy S, MoranSegura C, Messina J, Thomas KL, Darville L, Izumi V, Koomen JM, Pilon-Thomas SA, Ruffell B, Luca VC, Haltiwanger RS, Wang X, Wargo JA, Boland GM, Lau EK. Lester DK, et al. Among authors: izumi v. Nat Cancer. 2023 Feb;4(2):222-239. doi: 10.1038/s43018-022-00506-7. Epub 2023 Jan 23. Nat Cancer. 2023. PMID: 36690875 Free PMC article.
We report that dietary administration of L-fucose induces fucosylation and cell surface enrichment of the major histocompatibility complex (MHC)-II protein HLA-DRB1 in melanoma cells, triggering CD4(+) T cell-mediated increases in itICs and anti-tumor immunity, enhancing i …
We report that dietary administration of L-fucose induces fucosylation and cell surface enrichment of the major histocompatibility complex ( …
Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation.
Nakano K, Whitehead GS, Lyons-Cohen MR, Grimm SA, Wilkinson CL, Izumi G, Livraghi-Butrico A, Cook DN, Nakano H. Nakano K, et al. Among authors: izumi g. J Allergy Clin Immunol. 2024 Feb;153(2):487-502.e9. doi: 10.1016/j.jaci.2023.10.024. Epub 2023 Nov 11. J Allergy Clin Immunol. 2024. PMID: 37956733
BACKGROUND: Allergic asthma is driven largely by allergen-specific T(H)2 cells, which develop in regional lymph nodes on the interaction of naive CD4(+) T cells with allergen-bearing dendritic cells that migrate from the lung. ...Dendritic cells or fibroblastic reti …
BACKGROUND: Allergic asthma is driven largely by allergen-specific T(H)2 cells, which develop in regional lymph nodes on the interact …
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b.
Shibata K, Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki M, Shirai M, Yamasaki S. Shibata K, et al. Among authors: izumi y. Nat Commun. 2022 Nov 14;13(1):6948. doi: 10.1038/s41467-022-34802-8. Nat Commun. 2022. PMID: 36376329 Free PMC article.
MHC class I-related protein 1 (MR1) is a metabolite-presenting molecule that restricts MR1-reactive T cells including mucosal-associated invariant T (MAIT) cells. ...Bcl11b(iThy) mice lack conventional T cells and MAIT cells, whereas CD4(+)IL-18R(+) alphabeta …
MHC class I-related protein 1 (MR1) is a metabolite-presenting molecule that restricts MR1-reactive T cells including mucosal-associa …
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Tazawa R, et al. Among authors: izumi s. N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
Kuroda H, Oguri T, Kamiyama N, Toyoda H, Yasuda S, Imajo K, Suzuki Y, Sugimoto K, Akita T, Tanaka J, Yasui Y, Kurosaki M, Izumi N, Nakajima A, Fujiwara Y, Abe T, Kakisaka K, Matsumoto T, Kumada T. Kuroda H, et al. Among authors: izumi n. Radiology. 2023 Oct;309(1):e230341. doi: 10.1148/radiol.230341. Radiology. 2023. PMID: 37787670
Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels.
Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F. Fukunaga K, et al. Among authors: izumi h. J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18. J Pharmacol Sci. 2019. PMID: 30600144 Free article. Review.
Low-threshold Ca(2+) spikes are mediated by T-type Ca(2+) channels, which have electrophysiological properties of fast inactivation and slow deactivation kinetics. ...In this context, we overview our attempts leading to the development of a T-type Ca(2+) channel enh …
Low-threshold Ca(2+) spikes are mediated by T-type Ca(2+) channels, which have electrophysiological properties of fast inactivation a …
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.
Onishi Y, Furukawa E, Kamata M, Fukatsu M, Kameoka Y, Hatta S, Hamada H, Oyake T, Kai T, Sukegawa M, Nakajima S, Yanagiya R, Yamaguchi K, Takahashi T, Harazaki Y, Izumi T, Murai K, Ito S, Ikezoe T, Ishizawa K, Takahashi N, Harigae H. Onishi Y, et al. Among authors: izumi t. Int J Hematol. 2023 May;117(5):738-747. doi: 10.1007/s12185-023-03546-6. Epub 2023 Feb 9. Int J Hematol. 2023. PMID: 36757523
Early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) is generally considered to be a high-risk subtype. We retrospectively analyzed the clinical outcomes of adult patients diagnosed with ETP-ALL or other T-cell ALL (non-ETP T-ALL). The sub …
Early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) is generally considered to be a high-risk subtype. We retros …
[Drug-induced myocarditis].
Takehana H, Izumi T. Takehana H, et al. Among authors: izumi t. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:436-9. Nihon Rinsho. 2007. PMID: 18074577 Review. Japanese. No abstract available.
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T, Naito Y, Koyama S, Nakanishi Y, Masuhiro K, Izumi M, Kuge T, Naito M, Mizuno Y, Yamaguchi Y, Kang S, Yaga M, Futami Y, Nojima S, Nishide M, Morita T, Kato Y, Tsuda T, Takemoto N, Kinugasa-Katayama Y, Aoshi T, Villa JK, Yamashita K, Enokida T, Hoshi Y, Matsuura K, Tahara M, Takamatsu H, Takeda Y, Inohara H, Kumanogoh A. Hirai T, et al. Among authors: izumi m. JCI Insight. 2024 Feb 8;9(3):e166349. doi: 10.1172/jci.insight.166349. JCI Insight. 2024. PMID: 38329122 Free PMC article.
Immune checkpoint inhibitors (ICIs) are indicated for a diverse range of cancer types, and characterizing the tumor immune microenvironment is critical for optimizing therapeutic strategies, including ICIs. T cell infiltration and activation status in the tumor microenviro …
Immune checkpoint inhibitors (ICIs) are indicated for a diverse range of cancer types, and characterizing the tumor immune microenvironment …
4,095 results